Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Shigellosis | 0 | map05131 | clioquinol | 5892 | drug-path |
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | clioquinol | 5892 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | clioquinol | 5892 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | clioquinol | 5892 | drug-path |
Gap junction | R-HSA-190861 | map04540 | clioquinol | 5892 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | clioquinol | 5892 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | clioquinol | 5892 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | clioquinol | 5892 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | clioquinol | 5892 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | clioquinol | 5892 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | clioquinol | 5892 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | clioquinol | 5892 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | brinzolamide | 68844 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | brinzolamide | 68844 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | brinzolamide | 68844 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | verteporfin | 5094 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | verteporfin | 5094 | drug-path |
Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | verteporfin | 5094 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | verteporfin | 5094 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | verteporfin | 5094 | drug-path |